150 related articles for article (PubMed ID: 27431944)
1. Trichostatin A increases the TIMP-1/MMP ratio to protect against osteoarthritis in an animal model of the disease.
Qu H; Li J; Wu LD; Chen WP
Mol Med Rep; 2016 Sep; 14(3):2423-30. PubMed ID: 27431944
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of biochanin A on articular cartilage: in vitro and in vivo studies.
Wu DQ; Zhong HM; Ding QH; Ba L
BMC Complement Altern Med; 2014 Nov; 14():444. PubMed ID: 25398247
[TBL] [Abstract][Full Text] [Related]
3. Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.
Zhong Y; Huang Y; Santoso MB; Wu LD
Int J Clin Exp Pathol; 2015; 8(3):2365-74. PubMed ID: 26045743
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis.
Cai D; Yin S; Yang J; Jiang Q; Cao W
Arthritis Res Ther; 2015 Sep; 17():269. PubMed ID: 26408027
[TBL] [Abstract][Full Text] [Related]
5. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
Kim JH; Huh JE; Baek YH; Lee JD; Choi DY; Park DS
J Ethnopharmacol; 2011 Mar; 134(2):234-42. PubMed ID: 21182922
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis.
Chen WP; Bao JP; Hu PF; Feng J; Wu LD
Mol Biol Rep; 2010 Dec; 37(8):3967-72. PubMed ID: 20237852
[TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis chondrocytes.
Lee YJ; Lee EB; Kwon YE; Lee JJ; Cho WS; Kim HA; Song YW
Rheumatol Int; 2003 Nov; 23(6):282-8. PubMed ID: 12684836
[TBL] [Abstract][Full Text] [Related]
8. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model.
Nasu Y; Nishida K; Miyazawa S; Komiyama T; Kadota Y; Abe N; Yoshida A; Hirohata S; Ohtsuka A; Ozaki T
Osteoarthritis Cartilage; 2008 Jun; 16(6):723-32. PubMed ID: 18226559
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention.
Iliopoulos D; Malizos KN; Tsezou A
Ann Rheum Dis; 2007 Dec; 66(12):1616-21. PubMed ID: 17502362
[TBL] [Abstract][Full Text] [Related]
10. Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation.
Culley KL; Hui W; Barter MJ; Davidson RK; Swingler TE; Destrument AP; Scott JL; Donell ST; Fenwick S; Rowan AD; Young DA; Clark IM
Arthritis Rheum; 2013 Jul; 65(7):1822-30. PubMed ID: 23575963
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside‑Rg5 treatment inhibits apoptosis of chondrocytes and degradation of cartilage matrix in a rat model of osteoarthritis.
Zhang P
Oncol Rep; 2017 Mar; 37(3):1497-1502. PubMed ID: 28112382
[TBL] [Abstract][Full Text] [Related]
12. The effects of carboxymethylated chitosan on metalloproteinase-1, -3 and tissue inhibitor of metalloproteinase-1 gene expression in cartilage of experimental osteoarthritis.
Liu SQ; Qiu B; Chen LY; Peng H; Du YM
Rheumatol Int; 2005 Nov; 26(1):52-7. PubMed ID: 15765218
[TBL] [Abstract][Full Text] [Related]
13. Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes.
Sadowski T; Steinmeyer J
Osteoarthritis Cartilage; 2001 Jul; 9(5):407-15. PubMed ID: 11467888
[TBL] [Abstract][Full Text] [Related]
14. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal.
Dai SM; Shan ZZ; Nishioka K; Yudoh K
Ann Rheum Dis; 2005 May; 64(5):735-42. PubMed ID: 15834055
[TBL] [Abstract][Full Text] [Related]
15. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.
Zhong HM; Ding QH; Chen WP; Luo RB
Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614
[TBL] [Abstract][Full Text] [Related]
16. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
[TBL] [Abstract][Full Text] [Related]
17. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes.
Tung JT; Fenton JI; Arnold C; Alexander L; Yuzbasiyan-Gurkan V; Venta PJ; Peters TL; Orth MW; Richardson DW; Caron JP
Can J Vet Res; 2002 Jan; 66(1):19-25. PubMed ID: 11858644
[TBL] [Abstract][Full Text] [Related]
18. Lycorine protects cartilage through suppressing the expression of matrix metalloprotenases in rat chondrocytes and in a mouse osteoarthritis model.
Chen S; Fang XQ; Zhang JF; Ma Y; Tang XZ; Zhou ZJ; Wang JY; Qin A; Fan SW
Mol Med Rep; 2016 Oct; 14(4):3389-96. PubMed ID: 27509914
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of berberine in an experimental rat osteoarthritis model.
Hu PF; Chen WP; Tang JL; Bao JP; Wu LD
Phytother Res; 2011 Jun; 25(6):878-85. PubMed ID: 21108488
[TBL] [Abstract][Full Text] [Related]
20. Rebamipide attenuates pain severity and cartilage degeneration in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes.
Moon SJ; Woo YJ; Jeong JH; Park MK; Oh HJ; Park JS; Kim EK; Cho ML; Park SH; Kim HY; Min JK
Osteoarthritis Cartilage; 2012 Nov; 20(11):1426-38. PubMed ID: 22890185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
